Sort

Search

01/01/2022 Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction
Haberman D., Estévez-Loureiro R., Benito-Gonzalez T., Denti P., Arzamendi D., Adamo M., Freixa X., Nombela-Franco L., Villablanca P., Krivoshei L., Fam N., Spargias K., Czarnecki A., Pascual I., Praz F., Sudarsky D., Kerner A., Ninios V., Gennari M., Beeri R., Perl L., Wasserstrum Y., Danenberg H., Poles L., George J., Caneiro-Queija B., Scianna S., Moaraf I., Schiavi D., Scardino C., Corpataux N., Echarte-Morales J., Chrissoheris M., Fernández-Peregrina E., Pasquale M.D., Regueiro A., Vergara-Uzcategui C., Iñiguez-Romo A., Fernández-Vázquez F., Dvir D., Maisano F., Taramasso M., Shuvy M.. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction. EUROPEAN HEART JOURNAL. 2022; 43(7)DOI:10.1093/eurheartj/ehab496. PMID:34463727. IF:39.300(Q1/1D).
01/01/2022 Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing
González-Juanatey C., Anguita-Sánchez M., Barrios V., Núñez-Gil I., Gómez-Doblas J.J., García-Moll X., Lafuente-Gormaz C., Rollán-Gómez M.J., Peral-Disdie V., Martínez-Dolz L., Rodríguez-Santamarta M., Viñolas-Prat X., Soriano-Colomé T., Muñoz-Aguilera R., Plaza I., Curcio-Ruigómez A., Orts-Soler E., Segovia J., Maté C., Cequier Á.. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing. PLoS One. 2022; 17DOI:10.1371/journal.pone.0263277. PMID:35143527. IF:3.700(Q2/4D).
01/01/2022 Impact of operators experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry
Cruz-González I., Torres Saura F., Trejo-Velasco B., Antonio Fernández Díaz J., Fajardo Molina R., del Valle-Fernández R., Moreno Terribas G., Martí Sánchez D., López-Mínguez J.-R., Gomez-Blazquez I., Sanmartin Pena J.-C., Botas J., Martin Lorenzo P., Palazuelos J., Albarrán Rincon R., Mohandes M., Rodriguez Entem F.-J., Martí G., Valero E., Gutiérrez H., Amat-Santos I.J., Nombela-Franco L., Salinas P., Teruel L., Gomez-Hospital J.-A., Arzamendi D., Torres Sanabria M., Calle Pérez G., Cañadas Pruaño D., Pérez de Prado A., Benito González T., Arroyo-Úcar E., Estévez-Loureiro R., Caneiro-Queija B., Ibañez Criado J.L., Ruiz-Nodar J.M.. Impact of operators experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry. Ijc Heart & Vasculature. 2022; 38DOI:10.1016/j.ijcha.2021.100941. PMID:35024431. IF:(Q/D).
01/01/2022 Sensitivity Analysis of Left Atrial Wall Modeling Approaches and Inlet/Outlet Boundary Conditions in Fluid Simulations to Predict Thrombus Formation
Albors C., Mill J., Kjeldsberg H.A., Viladés Medel D., Olivares A.L., Valen-Sendstad K., Camara O.. Sensitivity Analysis of Left Atrial Wall Modeling Approaches and Inlet/Outlet Boundary Conditions in Fluid Simulations to Predict Thrombus Formation. Lecture Notes In Computer Science. 2022; 13593 LNCSDOI:10.1007/978-3-031-23443-9_17. PMID:. IF:(Q/D).
01/01/2022 Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
Diez-Lopez, C, Salazar-Mendiguchia, J, Garcia-Romero, E, Fuentes, L, Lupon, J, Bayes-Genis, A, Manito, N, De Antonio, M, Moliner, P, Zamora, E, Catala-Ruiz, P, Cainzos-Achirica, M, Comin-Colet, J, Gonzalez-Costello, J. Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy. Journal of Cardiovascular Development and Disease. 2022; 9(1)DOI:10.3390/jcdd9010020. PMID:35050230. IF:2.400(Q3/7D).
01/01/2022 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)
Glikson M., Nielsen J.C., Kronborg M.B., Michowitz Y., Auricchio A., Barbash I.M., Barrabes J.A., Boriani G., Braunschweig F., Brignole M., Burri H., Coats A.J.S., Deharo J.-C., Delgado V., Diller G.-P., Israel C.W., Keren A., Knops R.E., Kotecha D., Leclercq C., Merkely B., Starck C., Thylen I., Tolosana J.M., Leyva F., Linde C., Abdelhamid M., Aboyans V., Arbelo E., Asteggiano R., Barón-Esquivias G., Bauersachs J., Biffi M., Birgersdotter-Green U., Bongiorni M.G., Borger M.A., Celutkiene J., Cikes M., Daubert J.-C., Drossart I., Ellenbogen K., Elliott P.M., Fabritz L., Falk V., Fauchier L., Fernández-Aviles F., Foldager D., Gadler F., De Vinuesa P.G.G., Gorenek B., Guerra J.M., Hermann Haugaa K., Hendriks J., Kahan T., Katus H.A., Konradi A., Koskinas K.C., Law H., Lewis B.S., Linker N.J., Løchen M.-L., Lumens J., Mascherbauer J., Mullens W., Nagy K.V., Prescott E., Raatikainen P., Rakisheva A., Reichlin T., Ricci R.P., Shlyakhto E., Sitges M., Sousa-Uva M., Sutton R., Suwalski P., Svendsen J.H., Touyz R.M., Van Gelder I.C., Vernooy K., Waltenberger J., Whinnett Z., Witte K.K.. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA). EUROPACE. 2022; 24(1)DOI:10.1093/europace/euab232. PMID:34455427. IF:6.100(Q1/3D).
01/01/2022 Spanish Heart Transplant Registry. 33rd official report of the Heart Failure Association of the Spanish Society of Cardiology
González-Vílchez F., Gómez-Bueno M., Almenar-Bonet L., Crespo-Leiro M.G., Arizón del Prado J.M., Blázquez-Bermejo Z., Delgado-Jiménez J.F., de Antonio-Ferrer M., Sobrino-Márquez J.M., García-Romero E.. Spanish Heart Transplant Registry. 33rd official report of the Heart Failure Association of the Spanish Society of Cardiology. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.recesp.2022.06.001. PMID:35850486. IF:(Q/D).
01/01/2022 Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Piccini J.P., Caso V., Connolly S.J., Fox K.A.A., Oldgren J., Jones W.S., Gorog D.A., Viethen T., Neumann C., Mundl H., Patel M.R., Auer J., Hubauer M., Pandzic S., Preishuber E., Primus-Grabscheit C., Reitgruber D., Schmalzer F., Adlbrecht C., Schober A., Hajos J., Keil C., Schratter A., Frick M., Benda M.A., Mächler M., Mutschlechner B., Saely C., Sprenger L., Lichtenauer M., Eber M., Hoppe U., Kolbitsch T., Jirak P.M., Mirna M., Schönbauer R., Bergler-Klein J., Hengstenberg C., Stojkovic S., Scherr D., Manninger-Wünscher M., Rohrer U., Stühlinger M., Schgoer W., Schwarzl J., Pürerfellner H., Derndorfer M., Ebner C., Eder V., Kollias G., Sturmberger T., Sieghartsleitner S., Vijgen J., Koopman P., Dujardin K., Anné W., De Ceuninck M., Tavernier R., Duytschaever M., Knecht S., Missault L., Vandekerckhove Y., Rossenbacker T., Ector B., Charlier F., Debruyne P., Dewilde W., Janssens L., Roosen J., Vankelecom B., Heidbuchel H., Delesie M., Vervoort G., Rombouts H., Vanassche T., Engelen M., Verhamme P., Willems R., Constance C., Pranno N., Cox J., Bata I., Macle L., Aguilar M., Tourigny J.C., Dubuc M., Dyrda K., Guerra P., Khairy P., Mondésert B., Rivard L., Roy D., Tadros R., Talajic M., Thibault B., Nault I., Blier L., Champagne J., Molin F., O'Hara G., Philippon F., Plourde B., Sarrazin J.-F., Steinberg C., Coufal Z., Balazsik D., Mikulica M., Zapeca J., Cermak O., Drasnar T., Falc M., Hornof J., Racz B., Weissova D., Linkova H., Paskova E., Petr R., Sirakova A., Kettner J., Benak A., Holek M., Podpera I., Podperova M., Vancura V., Jandik T., Smid J., Dedek V., Banik J., Durdil V., Hnat T., Lellouche N., Rouffiac S., Taldir G., Bridonneau V., Couffon P., Daudin M., Hamon C., Lacaze J., Quentin A., Thebault C., Boiffard E., Billon O., Miette F., Pouliquen H., Turlotte G., Gorka H., Albert F., Bayle S., Bensaid R., Dasoveanu M., Demichili T., Dutoiu T., Khalil C., Loghin C., Range G., Roussel L., Socié P., Thuaire C., Extramiana F., Algalarrondo V., Boughanmi H., El Mansour N., Mohammad U., Sellier R., Elbaz M., Laperche C., Maury P., Kiss R., Borsanyi T., Gingl Z., Polgar B., Benczur B., Bodor A., Hepp T., Malati E., Nagy L., Erdei N., Kapus J., Kapus K., Toth B., Matoltsy A., Kiss T., Merkely B., Herczeg S., Kiss O., Sallo Z., Toth K., Habon T., Rabai M., Totsimon K., Zilahi Z., Bencze G., Santa J., Aradi D., Kelemen B., Bolognese L., Nesti M., Notarstefano P.G., D'Orazio S., Cosmi F., Becattini C., Agnelli G., Broccatelli B., Mosconi M.G., Paciaroni M., Urbini C., Parato V.M., Notaristefani C., Scarano M., Ameri P., Ghigliotti G., Guglielmi G., Lotti R., Merlo A.C., Muiesan M.L., Abondio A., Berasi C., Mattiuzzo E., Mutti C., Salvetti M., Pignatelli P., Menichelli D., Pastori D., Tamiya E., Matsumoto T., Takabe T., Yamashita H., Higashiue S., Furuya O., Hiramatsu N., Kasuga K., Kojima S., Komooka M., Kuroyanagi S., Matsuura M., Takemoto T., Yamamoto S., Saito K., Abe T., Ishida I., Iwanami Y., Kataoka S., Moriyama T., Murohashi A., Sasaki A., Nakamura Y., Ueno T., Shimane A., Hamana T., Ichibori H., Inoue T., Itoh M., Iwane S., Kawai H., Kokawa T., Masumoto A., Miyata T., Nakano S., Oishi S., Onishi T., Sawada T., Saito T., Shoda M., Takahashi N., Takaya T., Taniguchi Y., Tsukamoto S., Tsukishiro Y., Tsukiyama Y., Tsunamoto H., Uzu K., Yamamoto H., Yamamoto T., Yokoi K., Yoshida C., Watanabe N., Betsuyaku T., Adachi K., Awane K., Goto D., Sakakibara M., Watanabe M., Ueno H., Hiroe Y., Matsuo K., Ayata K., Fukuda K., Hata Y., Hashimoto K., Matsumi H., Nikaido A., Okamoto S., Sime I., Stirna V., Reinholde I., Hansone S., Kozlovska A., Romanova J., Klincare D., Pontaga N., Dirmans I., Kalnins A., Upite D., Gersamija A., Teleznikovs A., Rozkova N., Safro J., Anguera Camós I., Domenico Dallaglio P., Salguero Bodes R., Arnbas F., Borrego L., Marco A., Jimenez J.R., Gómez-Doblas J.J., Pérez Cabeza A., Ferreira Gonzålez I., Limeres Freire J., Lopez Grau M., Viñolas Prat X., Moreno Weidmann Z., Guerra Ramos J.M., Alonso Martin M.C., Campos Garcia B., Mogro Carranza J.M., Mendez Zurita F.J., Rodriguez Font E., Gonzales Matos C.E., García Hernando V., Lindholm C.-J., Thulin J., Wallén H., Hagwall K., Eliasson K., Lundvall M., Olsson J., Kjellman B., Lind M., Johansson L., Svedberg N., Berglund S., Söderberg J., Zedigh C., Mooe T., Axelsson M., Binsell E., Huber D., Müller C., Danier I., Kühne M., Okamura B., Schoepfer H., Simmen C., Reichlin T., Chollet L., Lam A., Wittmer S., Rickli H., Gall C., Hametner G., Intorp S., Luescher D., Haegeli L., Berg J.C., Ebrahimi R., Auricchio A., Crljenica C., Moccetti T., Monti C., Pasotti E., Petrova I., Rossi M., Mach F., Namdar M., de Groot J., Proost V., Neefs J., Linz D., van Stipdonk T., den Uijl D., Alings M., Schaap J., Segers D., Wouters N., Bartels L., Tieleman R., Pisters R., de Vries T., Selig J., Kuijper A., Bot P., Keijzers M., Verdel G., Tukkie R., van den Bos E., Kauer F., Oemrawsingh R., Stevenhagen J., van Es J., Lip G., Gupta D., Kotalczyk A., Gunstone A., Brixey R.D., Gorog D., Dinarvand D., Gue Y., Kanji R., Memtsas V., Senior R., Bioh G., Wong Y.-K., Child N.. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. LANCET. 2022; 399(10333)DOI:10.1016/S0140-6736(22)00456-1. PMID:35385695. IF:168.900(Q1/1D).
01/01/2022 A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
Rao S.V., Kirsch B., Bhatt D.L., Coppolecchia R., Eikelboom J., James S.K., Jones W.S., Keller L., Hermanides R.S., Campo G., Ferreiro J.L., Mundl H., Alexander J.H., Hengstenberg C., Steinwender C., Alber H., Steringer-Mascherbauer R., Schober A., Auer J., Roithinger F.X., Von Lewinski D., Moertl D., Huber K., Coussement P., Hoffer E., Beauloye C., Janssens L., Vranckx P., De Raedt H., Vanassche T., Vrolix M., Rokyta R., Parenica J., Pelouch R., Motovska Z., Alan D., Kettner J., Polasek R., Cermak O., Sedlon P., Hanis J., Novak M., Belohlavek J., Horacek T., Leggewie S., Wenzel P., Vom Dahl J., Sievers B., Pulz J., Schellong S., Clemmensen P., Muller-Hennessen M., Rassaf T., Falukozi J., Ruzsa Z., Tomcsanyi J., Csanadi Z., Herczeg B., Koszegi Z., Vorobcsuk A., Kiss R., Baranyai C., Dezsi C., Merkely B., Lupkovics G., Rossini R., Scherillo M., Sergio Saba P., Calo L., Nassiacos D., Quadri G., Sciahbasi A., Silvio Marenzi G.C., Reimers B., Perna G.P., Sacca S., Fattore L., Brunelli C., Picchi A., Kuramochi T., Kondo K., Aoyama T., Kudoh T., Yamamoto T., Takaya T., Mukai Y., Fukui K., Morioka N., Ando K., Yamamuro A., Morita Y., Koga Y., Watanabe T., Sakamoto T., Shibasaki T., Maebuchi D., Takahashi A., Yonetsu T., Kakuta T., Nishina H., Oemrawsingh R., Dorman R., Oude Ophius T., Prins P., Al Windy N.Y.Y., Zoet-Nugteren S.K., Hermanides R., Van Eck M., Scherptong R., Cornel J.H., Damman P., Bech G., Torquay R., Kietselaer B., Grzelakowski P., Krzysztof D., Budaj A., Miekus P., Przybylski A., Zarebinski M., Balsam P., Szachniewicz J., Gierlotka M., Tycinska A., Iniguez Romo A., Fernandez Ortiz A., Carrasquer Cucarella A., Sanmartin Fernandez M., Sionis A., Bueno Zamora H., Ferreiro Gutierrez J.L., Almenar L., Ferreira Gonzalez I., Pascual Figal D.A., Almendro Delia M., Jimenez Fernandez M., Skeppholm M., Zedigh C., Angeras O., Lauermann J., Erlinge D., Gustafsson R., Mooe T., Utreras A., James S., Grimfjard P., Pedrazzini G., Mach F., Fournier S., Haegeli L., Beer J.H., Leibundgut G., Kobza R., Kaiser C., Kunadian V., Al-Lamee R., Gorog D., Khan S., Trevelyan J., Toor I., Smith J., Purushottam B., Treasure C., Arena F., Vedere A., Henderson D., Gilani S., Jones A., Carrillo-Jimenez R., Gillespie E., Marhefka G., Wang D., Olson C., Bloom S., Iftikhar F., Brabham D., McGinty J., Thompson C., Talano J., Ginete W., Williams M., Masud A., Ariani M., Bitar F., Wang T., Samuelson B.. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction. CIRCULATION. 2022; 146(16)DOI:10.1161/CIRCULATIONAHA.122.061612. PMID:36030390. IF:37.800(Q1/1D).
01/01/2022 Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants
Corrochano M., Acosta-Isaac R., Plaza M., Muñoz R., Mojal S., Moret C., Souto J.C.. Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants. PLoS One. 2022; 17(12)DOI:10.1371/journal.pone.0278693. PMID:36490245. IF:3.700(Q2/4D).
01/01/2022 Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio
Radike M., Ben-Aicha S., Gutiérrez M., Hidalgo A., Badimón L., Vilahur G.. Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 76(2)DOI:10.1016/j.recesp.2022.06.007. PMID:35809893. IF:5.900(Q1/3D).
01/01/2022 European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
Lee G.A., Aktaa S., Baker E., Gale C.P., Yaseen I.F., Gulati G., Asteggiano R., Szmit S., Cohen-Solal A., Abdin A., Jurczak W., Garrido Lopez P., Sverdlov A.L., Tocchetti C.G., Barac A., Parrini I., Zamorano P., Iakobishvili Z., Pudil R., Badimon L., Kirby A.M., Blaes A.H., Farmakis D., Curigliano G., Stephens R., Lyon A.R., Lopez-Fernandez T.. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment. European Heart Journal-Quality of Care and Clinical Outcomes. 2022; 9(1)DOI:10.1093/ehjqcco/qcac070. PMID:36316010. IF:5.200(Q2/3D).
01/01/2022 Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients
Pérez de Isla L., Alonso R., Argüeso R., Muñiz-Grijalvo O., Álvarez-Baños P., Badimón L., Watts G.F., Mata P.. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients. Journal of Clinical Lipidology. 2022; 16(5)DOI:10.1016/j.jacl.2022.07.007. PMID:35906178. IF:4.400(Q2/3D).
01/01/2022 Percutaneous tricuspid valve repair after orthotopic heart transplantation
Maestro Benedicto A., Asmarats Serra L., Li C.H.P., Mirabet Pérez S.. Percutaneous tricuspid valve repair after orthotopic heart transplantation. Rec: Cardioclinics. 2022; 57(2)DOI:10.1016/j.rccl.2021.12.002. PMID:. IF:(Q/D).
01/01/2022 Systems Biology in Chronic Heart Failure—Identification of Potential miRNA Regulators
Vilella-Figuerola A., Gallinat A., Escate R., Mirabet S., Padró T., Badimon L.. Systems Biology in Chronic Heart Failure—Identification of Potential miRNA Regulators. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(23)DOI:10.3390/ijms232315226. PMID:36499552. IF:5.600(Q1/3D).
01/01/2022 Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone
Jimenez-Altayo, F, Marzi, J, Galan, M, Dantas, AP, Ortega, M, Rojas, S, Egea, G, Schenke-Layland, K, Jimenez-Xarrie, E, Planas, AM. Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2022; 42(1)DOI:10.1177/0271678X211033362. PMID:34474613. IF:6.300(Q1/2D).
01/01/2022 Human Lysyl Oxidase Over-Expression Enhances Baseline Cardiac Oxidative Stress but Does Not Aggravate ROS Generation or Infarct Size Following Myocardial Ischemia-Reperfusion
Valls-Lacalle, L, Puertas-Umbert, L, Varona, S, Martinez-Gonzalez, J, Rodriguez, C, Rodriguez-Sinovas, A. Human Lysyl Oxidase Over-Expression Enhances Baseline Cardiac Oxidative Stress but Does Not Aggravate ROS Generation or Infarct Size Following Myocardial Ischemia-Reperfusion. Antioxidants. 2022; 11(1)DOI:10.3390/antiox11010075. PMID:35052579. IF:7.000(Q1/1D).
01/01/2022 Eficacia y seguridad de dosis altas de irinotecán en pacientes con cáncer colorrectal metastásico tratados con el esquema FOLFIRI en función del genotipo de UGT1A1: Revisión sistemática
Miarons M., Riera P., García-Gil S., Gutiérrez-Nicolás F.. Eficacia y seguridad de dosis altas de irinotecán en pacientes con cáncer colorrectal metastásico tratados con el esquema FOLFIRI en función del genotipo de UGT1A1: Revisión sistemática. Farmacia Hospitalaria. 2022; 46(4)DOI:10.7399/fh.11736. PMID:36183220. IF:(Q/D).
01/01/2022 Monitoring Atheroprotective Macrophage Cholesterol Efflux In Vivo
Rivas-Urbina A., Rotllan N., Santos D., Julve J., Sanchez-Quesada J.L., Escolà-Gil J.C.. Monitoring Atheroprotective Macrophage Cholesterol Efflux In Vivo. Methods In Molecular Biology. 2022; 2419DOI:10.1007/978-1-0716-1924-7_35. PMID:. IF:(Q/D).
01/01/2022 Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis
Rivas-Urbina A., Rotllan N., Santos D., Julve J., Escolà-Gil J.C., Sanchez-Quesada J.L.. Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis. Methods In Molecular Biology. 2022; 2419DOI:10.1007/978-1-0716-1924-7_17. PMID:. IF:(Q/D).